Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age-Reference-Cited by-同舟云学术

Prevention of Bone Loss with Alendronate in Postmenopausal Women under 60 Years of Age

Published:1998-02-19 Issue:8 Volume:338 Page:485-492
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Hosking David,Chilvers Clair E.D.,Christiansen Claus,Ravn Pernille,Wasnich Richard,Ross Philip,McClung Michael,Balske Ana,Thompson Desmond,Daley Marianne,Yates A. John

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJM199802193380801

Cited by 451 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bisphosphonates do not affect healing of a critical-size defect in estrogen-deficient mice;Bone Reports;2024-03

2. Follow-up bone mineral density testing: 2023 official positions of the International Society for Clinical Densitometry;Journal of Clinical Densitometry;2024-01

3. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials;BMJ;2023-05-02

4. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools;Systematic Reviews;2023-03-21

5. Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice;Osteoporosis International;2023-01-04